Dicerna Pharmaceuticals Inc (OQ:DRNA)

INK Ultra Money Free

INK Ultra Money Premium

Get a Canadian Insider Club Ultra subscription for

  • Insider filing email alerts
  • Access to premium INK Research reports
  • Full access to weekly North America Top filer reports
  • Ad-free browsing
  • INK Ultra Money premium content

(already an Ultra member? Please log into your account for access)

Latest 10 SEC filings (by transaction date) for DRNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 14th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 11/19 Dec 11/19 Green John B Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -8,000  
Dec 11/19 Dec 11/19 Green John B Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,000 $5.45
Dec 6/19 Dec 4/19 Koppel Adam Indirect Ownership Common Stock S - Open market or private sale -1,500,000 $24.68
Dec 2/19 Dec 2/19 Kolchinsky Peter Indirect Ownership Common Stock S - Open market or private sale -137,176 $24.98
Dec 3/19 Dec 2/19 Weissman James B Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -20,000  
Dec 3/19 Dec 2/19 Weissman James B Direct Ownership Common Stock S - Open market or private sale -20,000 $26.00
Dec 3/19 Dec 2/19 Weissman James B Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 20,000 $2.97
Dec 2/19 Nov 29/19 Kolchinsky Peter Indirect Ownership Common Stock S - Open market or private sale -138,000 $24.22
Dec 2/19 Nov 27/19 Kolchinsky Peter Indirect Ownership Common Stock S - Open market or private sale -368,700 $24.04
Nov 26/19 Nov 26/19 Kolchinsky Peter Indirect Ownership Common Stock S - Open market or private sale -239,700 $23.59
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for DRNA within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET December 14th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Dec 11/19 Dec 11/19 Green John B Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -8,000  
Dec 11/19 Dec 11/19 Green John B Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 8,000 $5.45
Dec 6/19 Dec 4/19 Koppel Adam Indirect Ownership Common Stock S - Open market or private sale -1,500,000 $24.68
Dec 3/19 Dec 2/19 Weissman James B Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -20,000  
Dec 3/19 Dec 2/19 Weissman James B Direct Ownership Common Stock S - Open market or private sale -20,000 $26.00
Dec 3/19 Dec 2/19 Weissman James B Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 20,000 $2.97
Dec 2/19 Dec 2/19 Kolchinsky Peter Indirect Ownership Common Stock S - Open market or private sale -137,176 $24.98
Dec 2/19 Nov 29/19 Kolchinsky Peter Indirect Ownership Common Stock S - Open market or private sale -138,000 $24.22
Dec 2/19 Nov 27/19 Kolchinsky Peter Indirect Ownership Common Stock S - Open market or private sale -368,700 $24.04
Nov 27/19 Nov 25/19 Green John B Direct Ownership Employee Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -12,500  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $DRNA